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Laccase-catalyzed degradation of a broad spectrum of trace organic contaminants (TrOCs) by a 19 
membrane distillation (MD)-enzymatic membrane bioreactor (EMBR) was investigated. The MD 20 
component effectively retained TrOCs (94-99%) in the EMBR, facilitating their continuous biocatalytic 21 
degradation. Notably, the extent of TrOC degradation was strongly influenced by their molecular 22 
properties. A significant degradation (above 90%) of TrOCs containing strong electron donating 23 
functional groups (e.g., hydroxyl and amine groups) was achieved, while a moderate removal was 24 
observed for TrOCs containing electron withdrawing functional groups (e.g., amide and halogen groups).  25 
Separate addition of two redox-mediators, namely syringaldehyde and violuric acid, further improved 26 
TrOC degradation by laccase. However, a mixture of both showed a reduced performance for a few 27 
pharmaceuticals such as primidone, carbamazepine and ibuprofen. Mediator addition increased the 28 
toxicity of the media in the enzymatic bioreactor, but the membrane permeate (i.e., final effluent) was 29 
non-toxic, suggesting an added advantage of coupling MD with EMBR.  30 
 31 

















Membrane distillation (MD) is a low temperature distillation process in contrast to conventional 47 
distillation processes such as fractional or steam distillation. It essentially relies on the transport of water 48 
in the vapor phase from a feed solution through a microporous hydrophobic membrane to the permeate or 49 
distillate. Among different MD configurations, direct contact membrane distillation (DCMD) has been 50 
predominantly studied due to the ease of its operation (Alkhudhiri et al., 2012; Curcio & Drioli, 2005). In 51 
DCMD, the temperature of the feed solution is maintained at 15-20 ºC higher than the permeate to create 52 
an adequate vapor pressure difference, which allows water to pass through a microporous membrane in 53 
vapor form via diffusion (Alkhudhiri et al., 2012; Duong et al., 2017). Since mass transfer occurs in 54 
gaseous phase, MD can theoretically achieve complete rejection of all non-volatile compounds (Martinetti 55 
et al., 2009; Wijekoon et al., 2014a).  56 
Due to efficient separation efficiency, low fouling propensity and potentially low energy requirement 57 
(subject to the availability of low grade heat), stand-alone MD has been studied for applications such as 58 
protein recovery in dairy processing (Hausmann et al., 2013), treatment of industrial (Khaing et al., 2010) 59 
and municipal wastewater (Phattaranawik et al., 2008; Wijekoon et al., 2014b), as well as for the removal 60 
of trace organic contaminant (TrOCs), such as pharmaceuticals and personal care products, pesticides and 61 
industrial chemicals, from wastewater (Darowna et al., 2014; Wijekoon et al., 2014a). Recently, TrOC 62 
removal has also been investigated by coupling an activated sludge based bioreactor to MD that achieved 63 
excellent (95-99%) TrOC retention (Wijekoon et al., 2014b). Since effective retention of TrOCs by the 64 
MD theoretically decouples organic retention time from hydraulic retention time of a bioreactor, the 65 
degradation of TrOCs is expected to improve due to prolonged contact time between the recalcitrant 66 
compounds and the microorganisms (Luo et al., 2014a). However, it was found that the biodegradation of 67 
resistant TrOCs, such as those containing strong electron withdrawing functional groups (EWGs), by the 68 
activated sludge in the MD-coupled bioreactor did not improve, and eventually these TrOCs accumulated 69 
in the bioreactor (Hai et al., 2014; Wijekoon et al., 2014b). Hence, to realize the full potential of a 70 
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combined biological - MD process, it is necessary to find the means to improve biodegradation of TrOCs 71 
retained in the bioreactor by the MD membrane. In this context, it is noteworthy that the oxidoreductase 72 
enzyme laccase (EC 1.10.3.2) can degrade TrOCs that are less susceptible to degradation by the activated 73 
sludge process (Cruz-Morató et al., 2014; Yang et al., 2013).  74 
Laccase can catalyze the degradation of a broad spectrum of pollutants including aromatic hydrocarbons, 75 
aliphatic amines and TrOCs by using dissolved oxygen as a co-substrate (Asif et al., 2017b; Hai et al., 76 
2007; Yang et al., 2013). However, its larger scale application is restricted by the lack of a reactor system, 77 
which can prevent washout of enzymes along with treated effluent. In a recent study, Asif et al. (2017c) 78 
combined an enzymatic bioreactor with the MD (MD - Enzymatic membrane bioreactor or MD-EMBR), 79 
which retained both laccase and the tested TrOCs (carbamazepine, sulfamethoxazole, diclofenac, atrazine 80 
and oxybenzone). During a short term (12 h) batch operation of the MD-EMBR (Asif et al., 2017c), 81 
degradation of the investigated TrOCs by laccase was found to improve significantly compared to that 82 
achieved by an activated sludge-based MD bioreactor (Wijekoon et al., 2014b). Furthermore, TrOC 83 
degradation by the MD-EMBR was better than those achieved by previously developed ultrafiltration 84 
(UF)-EMBRs, which retained laccase but not TrOCs (Asif et al., 2017c; Nguyen et al., 2016). Apparently, 85 
the effective retention of the TrOCs by the MD membrane also improved their biodegradation. The initial 86 
observations were promising but it is necessary to assess the performance of MD-EMBR for a wide range 87 
of TrOCs during continuous operation.  88 
This study aims to evaluate the performance of the MD-EMBR system for the degradation of a set of 30 89 
TrOCs with diverse physicochemical properties following their effective retention by the MD membrane. 90 
Redox mediators, which are low molecular weight substrates of laccase, can enhance enzymatic 91 
degradation (Yang et al., 2013). Thus, additionally, the effect of dosing two redox-mediators viz violuric 92 
acid (VA) and syringaldehyde (SA), separately and as a mixture, on TrOC degradation and laccase 93 
stability was investigated. Redox mediators can improve degradation but may increase the toxicity of the 94 
treated effluent (Ashe et al., 2016; Nguyen et al., 2016), therefore, the toxicity of the bioreactor media and 95 
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MD permeate (i.e., final effluent) to bacteria was monitored to clarify the applicability of this treatment 96 
process. Finally, during continuous operation, TrOC retention by MD can decrease over time due to 97 
‘membrane wetting’ or loss of hydrophobicity (Alkhudhiri et al., 2012; Duong et al., 2017). Accordingly, 98 
the effect of laccase and redox-mediators on the MD performance was also investigated.  99 
2. Materials and methods 100 
2.1. TrOCs, laccase and mediators 101 
A synthetic wastewater containing a mixture of 30 TrOCs in Milli-Q water was prepared for this study. 102 
These compounds were selected to represent different common classes of TrOCs, viz pharmaceutical and 103 
personal care products, industrial chemicals, steroid hormones and pesticides, which are commonly 104 
detected in different environmental systems (Luo et al., 2014b). A complete list along with their chemical 105 
structures appears in Supplementary Data. Relevant physicochemical properties of the selected TrOCs 106 
such as hydrophobicity (log D) and volatility (pKH) are given in Table 1. Analytical grade TrOCs were 107 
purchased from Sigma Aldrich (Australia). A stock solution (25 mg/L) containing the mixture of 30 108 
TrOCs was prepared in methanol, and kept in dark at -18 ºC prior to use.  109 
[Table 1] 110 
Laccase from genetically modified Aspergillus oryzae (Novozymes Australia Pty Ltd.) was used in this 111 
study. According to the supplier, the molecular weight of this laccase is 56 kDa. It has a purity of 112 
approximately 10% (w/w), density of 1.12 g/mL, and activity (measured using 2,6-dimethoxy phenol, 113 
DMP, as substrate) of 150,000 µM(DMP)/min. One of the main factors governing the laccase-catalyzed 114 
degradation of a substrate is the relative oxidation reduction potential (ORP) of that substrate and laccase 115 
(Yang et al., 2013). In this study, the ORP of the laccase, measured using an ORP meter (see section 116 
2.4.2), was 0.3 V. 117 
Two analytical grade natural redox-mediators, namely violuric acid (VA) and syringaldehyde (SA) 118 
(Sigma Aldrich, Australia), were used. A separate stock solution (50 mM) of each mediator was prepared 119 
in ultrapure Milli-Q water, and stored at 4 ºC in the dark. SA and VA produce highly reactive phenoxyl 120 
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and aminoxyl radicals, respectively. They can mediate TrOC degradation by following a hydrogen atom 121 
transfer pathway (Ashe et al., 2016; Asif et al., 2017b). The physicochemical properties of redox-122 
mediators are presented in Supplementary Data.   123 
2.2. The MD-EMBR System  124 
A laboratory scale MD-EMBR system was used comprising a glass enzymatic bioreactor (1.5 L) and an 125 
external direct contact membrane distillation (DCMD) module. A schematic of the setup is available in 126 
Supplementary Data. The enzymatic bioreactor was covered with aluminum foil and was placed in a 127 
water bath maintained at 30±0.2 oC using an immersion heating unit (Julabo, Germany). The enzymatic 128 
bioreactor was equipped with an air pump (ACO-002, Zhejiang Sensen Industry Co. Ltd., Zhejiang, 129 
China) to maintain the dissolved oxygen concentration at around 3 mg/L.  130 
The external DCMD module contained an acrylic glass membrane cell, two circulation pumps 131 
(Micropump Inc., USA) and a glass permeate tank. Feed and permeate flow channels were engraved on 132 
each block of the membrane cell. The length, width and height of each flow channel were 145, 95 and 3 133 
mm, respectively. The media from the glass enzymatic bioreactor and water from the permeate tank were 134 
passed through the membrane cell and then returned back to the enzymatic bioreactor and permeate tank, 135 
respectively. A chiller (SC100-A10, Thermo Scientific, USA) was used to regulate the temperature of the 136 
permeate tank at 10±0.1 oC. The permeate tank was also placed on a precision balance (Mettler Toledo 137 
Inc, USA) to monitor permeate flux. The recirculation flow rate of both feed and the distillate was 138 
controlled at 1 L/min (corresponding to a cross flow velocity of 9 cm/s) using two rotameters.  139 
A hydrophobic microporous flat-sheet polytetrafluoroethylene (PTFE) membrane (GE, Minnetonka, MN) 140 
was used in this study. The PTFE membrane had a nominal pore size of 0.2 µm, thickness of 175 µm, 141 
porosity of 70% and an active layer thickness of 5 µm (Nghiem & Cath, 2011).  142 
2.3. Experimental protocol 143 
After confirming the retention of laccase by the MD membrane, a series of experiments were conducted 144 
to investigate TrOC retention (by MD membrane) and enzymatic degradation with and without the 145 
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addition of mediators (i.e., SA and VA). The initial laccase activity and TrOC concentration in the 146 
enzymatic bioreactor of MD-EMBR was 95-100 µM(DMP)/min and 20 µg/L, respectively. It is noteworthy 147 
that laccase activity in the enzymatic bioreactors may gradually diminish due to various physicochemical 148 
and biological inhibitors such as shear stress caused by membrane filtration (Asif et al., 2017a). Hence, 149 
the laccase activity was maintained at 95-100 µM(DMP)/min by injecting a small dose of laccase (275 and 150 
400 µL per liter of reactor volume for laccase and laccase-mediator, respectively) every 12 h to sustain 151 
MD-EMBR operation.  152 
The MD-EMBR was first operated for a period of 60 h (i.e., 2× HRT) in a continuous mode (i.e., 153 
continuous withdrawal of treated effluent) without the addition of mediators. The enzymatic bioreactor 154 
was replenished with synthetic wastewater every time the water recovery reached 70% (i.e., 155 
approximately around every 24 h). Feed, bioreactor supernatant and treated effluent (i.e., MD-permeate) 156 
samples were collected after 30 and 60 h of MD-EMBR operation for TrOC quantification. The effect of 157 
individual mediators and SA-VA mixture on TrOC degradation was investigated in additional runs. A 158 
single dose of an individual redox-mediator (SA or VA at 0.5 mM) or their mixture (0.25 mM SA and 159 
0.25 mM VA) was added to the enzymatic bioreactor at the beginning of a run. Again, two sets of feed, 160 
supernatant and permeate samples for TrOC quantification were collected.  161 
2.4. Analytical methods 162 
2.4.1. TrOC analysis 163 
TrOCs were analyzed by solid phase extraction (SPE) and quantitative determination by a Shimadzu 164 
GC/MS (QP5000) system (Hai et al., 2011; Wijekoon et al., 2014b). TrOCs present in the feed, 165 
supernatant and permeate samples were extracted using 6 mL 200 mg Oasis HLB cartridges (Waters, 166 
Milford, MA, USA). The TrOC extraction procedure was as follows: (i) pre-conditioning of HLB 167 
cartridge with 5 mL dichloromethane and methanol solution (1:1 v/v), 5 mL methanol and 5 mL Milli-Q 168 
water; (ii) loading of acidified (pH 2-2.5) samples onto the cartridges at a flow rate of 1–4 mL/min; and 169 
(iii) drying of cartridges with nitrogen for 30 min. The TrOCs were subsequently eluted from the 170 
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cartridge using 5 mL of methanol followed by dichloromethane and methanol mixture (1:1 v/v) at a flow 171 
rate of 1–4 mL/min. The effluent was subsequently evaporated at 40 oC under a gentle stream of nitrogen. 172 
The residual after evaporation was re-dissolved in 200 µL methanol containing an internal standard (5 mg 173 
bisphenol A-d16) before its transfer into 1.5 mL vials. The mixture present in 1.5 mL vials was again 174 
evaporated under gentle stream of nitrogen. Finally, the extracts were derivatized by adding 100 µL of 175 
N,O-bis(trimethylsilyl)trifluoroacetamide (1% trimethylchlorosilane) and pyridine (dried with KOH 176 
solid), then heated on a heating block (60–70 oC) for 30 min. The derivatives were cooled to room 177 
temperature and analyzed using the Shimadzu QP5000 GC–MS (Shimadzu, Kyoto, Japan). The limit of 178 
detection (LOD) for this method is compound specific and ranged from 1-20 ng/L as listed in 179 
Supplementary Data. Removal efficiency by enzymatic reactor (R1) and MD-EMBR (R2) was calculated 180 
as shown in equation (1) and (2), respectively:   181 
100	 1  (1) 
100 1  (2) 
Where, Cf, Csu and Cp are the concentration (ng/L) of a specific TrOC in the feed, supernatant and 182 
permeate, respectively. The enzymatic transformation/degradation was calculated as follows:  183 
Cf × Vf  = (Csu × Vsu) + (Cp × Vp) + biodegradation/biotransformation  (3) 
Where, Vf, Vsu and Vp represents the volume of feed, supernatant and permeate, respectively. 184 
2.4.2. Laccase activity, ORP, toxicity and contact angle 185 
Laccase activity and effluent toxicity were examined as described elsewhere (Nguyen et al., 2016). 186 
Enzymatic activity was determined by recording the change in absorbance at 468 nm due to the oxidation 187 
of 2,6-dimethoxyl phenol (DMP) in the presence of 100 mM sodium citrate (pH 4.5). Laccase activity 188 
expressed as µM(DMP)/min was then calculated using its molar extinction coefficient of 49.6/mM.cm. ORP 189 
was measured using an ORP meter (WP-80D dual pH-mV meter, Thermo Fisher Scientific, Australia).  190 
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Samples for toxicity analysis were collected from the enzymatic bioreactor and permeate tank at the end 191 
of each experiment. Toxicity, expressed as a relative toxicity unit (rTU), was analyzed by measuring the 192 
inhibition of luminescence in the naturally bioluminescent bacteria Photobacterium leiognathi using the 193 
BLT-Screen as previously described by van de Merwe and Leusch (2015).  194 
The contact angle of the membrane surface was measured using a Rame-Hart Goniometer (Model 250, 195 
Rame-Hart, Netcong, New Jersey, USA) using the standard sessile drop method, with Milli-Q water 196 
being used as the reference liquid (Duong et al., 2016).  197 
3. Results and discussion 198 
3.1. Overall TrOC removal by MD-EMBR 199 
Retention by the MD membrane and degradation in the enzymatic bioreactor are two major mechanisms 200 
for TrOC removal in the MD-EMBR system. TrOC retention/removal by the MD membrane is governed 201 
by the vapor pressure (indicated by Henry’s constant, H or, pKH = -log H; Table 1) and the water partition 202 
coefficient (log D; Table 1) of the target TrOC. In a stand-alone MD system, a low (<2.5) ‘pKH /log D’ 203 
ratio suggests poor removal of the target compound (Wijekoon et al., 2014a). By contrast, the MD 204 
membrane coupled to an activated sludge bioreactor may achieve high removal of the target compounds 205 
irrespective of their pKH /log D ratio. This is because a compound with a low pKH /log D ratio tends to be 206 
adsorbed on the bioreactor particles (Wijekoon et al., 2014b). Although the enzymatic bioreactor was free 207 
of any suspended particles that can potentially adsorb TrOCs, MD-EMBR still achieved 94 to over 99% 208 
removal for the 30 TrOCs tested (Figure 1). It is noteworthy that compared to their partial removal (54-209 
70%) in a stand-alone MD system (Wijekoon et al., 2014a), the permeate from the MD-EMBR in the 210 
current study achieved over 99% removal of some TrOCs including 4-tert-octylphenol (pKH /log D = 211 
0.98), octocrylene (pKH /log D = 1.21), 4-tert-butylphenol (pKH /log D = 1.51), benzophenone (pKH /log 212 
D = 1.83) and oxybenzone (pKH /log D = 2.1). This significant improvement can be attributed to the 213 




3.2. TrOC degradation in MD-EMBR 216 
Laccase degrades a substrate via a radical-catalyzed mechanism. In this process, transfer of one electron 217 
from a substrate to laccase occurs, and molecular oxygen is reduced to water. Laccase can efficiently 218 
degrade phenolic pollutants i.e., substrates containing a hydroxyl (–OH) group attached to a benzene ring. 219 
On the other hand, non-phenolic pollutants are less amenable to laccase-catalyzed degradation (Asif et al., 220 
2017b; Yang et al., 2013). Therefore, degradation of phenolic and non-phenolic TrOCs are discussed 221 
separately.   222 
3.2.1. Degradation of phenolic TrOCs 223 
Of the 13 phenolic TrOCs tested (Figure 1), laccase achieved significant degradation (95-99%) of 10 224 
compounds including five steroid hormones, three industrial chemicals (bisphenol A, 4-tert-butylphenol 225 
and 4-tert-octylphenol) and two ingredients of personal care products (triclosan and oxybenzone). The 226 
observation of efficient enzymatic degradation of these TrOCs in MD-EMBR is consistent with the 227 
literature regarding previously developed enzymatic bioreactors. For example, Lloret et al. (2012) 228 
achieved 95-99% removal of two steroid hormones (estrone and 17β–estradiol) in a batch enzymatic 229 
bioreactor. Similarly, efficient degradation (>90%) of oxybenzone, bisphenol A, triclosan and 4-tert-230 
butylphenol has been achieved by batch or continuous flow enzymatic bioreactors (Margot et al., 2013; 231 
Nguyen et al., 2016). Notably, compared to that achieved by UF-EMBRs (Nguyen et al., 2015), in this 232 
study, degradation of estrone, 17β-estradiol and estriol was greater than 99%, which indicates that 233 
effective retention of these TrOCs by the MD membrane facilitated their degradation by laccase in MD-234 
EMBR. 235 
Although phenolic TrOCs are especially amenable to laccase-catalyzed degradation, moderate 236 
degradation of a few phenolic compounds has been previously attributed to the presence of EWG(s) in 237 
their molecular structure (d’Acunzo et al., 2006). Due to the steric hindrance caused by the concomitant 238 
presence of an EWG, phenolic TrOCs cannot access the active sites of laccase for efficient degradation 239 
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(d’Acunzo et al., 2006; Nguyen et al., 2016). In line with this, a moderate degradation (44-65%) was 240 
observed for three phenolic TrOCs, namely salicylic acid, pentachlorophenol and enterolactone in this 241 
study, which contain an EWG (i.e., carbonyl or halogen) in their molecule (Figure 1).  242 
3.2.2. Degradation of non-phenolic TrOCs 243 
Laccase can oxidize non-phenolic TrOCs, but the extent of the degradation may not be significant (Yang 244 
et al., 2013). In previous studies, two distinct trends were observed for the degradation of non-phenolic 245 
TrOCs by laccase: (i) poor removal (e.g., less than 5%) of those that only contain strong EWGs such as 246 
halogen (–X), amide (–CONR2) and carbonyl (–C=O); and (ii) moderate to high removal of those that 247 
contain both EWGs and electron donating functional groups (EDGs) such as amine (–NH2) or alkoxy (–248 
OR) (Asif et al., 2017a; Ji et al., 2016; Yang et al., 2013). In this study, benzophenone, octocrylene and 249 
amitriptyline were significantly degraded (>95%) by laccase. On the other hand, a moderate degradation 250 
(45-75%) was observed for the remaining non-phenolic TrOCs (Figure 1).   251 
Of particular interest is the enhanced degradation of pharmaceuticals and pesticides (containing strong 252 
EWGs) that were previously reported to be poorly (<10%) degraded by laccase in both batch and 253 
continuous flow enzymatic bioreactors (Margot et al., 2013; Nguyen et al., 2016). These TrOCs include 254 
ketoprofen (EWG carboxylic; 52% removal), clofibric acid (EWG halogen; 55% removal), 255 
carbamazepine (EWG amide; 62% removal), metronidazole (EWG nitro; 67% removal), atrazine (EWG 256 
halogen; 59% removal), fenoprop (EWG halogen, 48% removal) and N, N-Diethyl-meta-toluamide 257 
(DEET; EWG amide; 69% removal) (Figure 1). In a previous study, significantly improved degradation 258 
of recalcitrant TrOCs such as carbamazepine, atrazine and diclofenac was attributed to simultaneous 259 
adsorption of laccase and TrOCs on granular activated carbon which allowed prolonged close contact 260 
between laccase and TrOCs (Nguyen et al., 2014b). Although our approach was different, the enhanced 261 
degradation of recalcitrant TrOCs in MD-EMBR can be ascribed to the increased contact time between 262 
laccase and TrOCs following their complete retention (95-99% removal) by the MD membrane.  263 
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It is also noteworthy that TrOCs containing EDGs such as hydroxyl and amine (e.g., steroid hormones, 264 
bisphenol A and triclosan) can act as bi-functional substrates or redox-mediators (d’Acunzo et al., 2006; 265 
Hachi et al., 2017). Fragments of phenoxyl radicals or oxidative coupling agents (e.g., dimers) produced 266 
due to the oxidation of bi-functional substrates can facilitate the degradation of recalcitrant TrOCs via 267 
enzymatic and/or non-enzymatic reactions (e.g., polymerization or agglomeration). Indeed, Margot et al. 268 
(2013) reported significantly higher diclofenac removal in presence of  the phenolic TrOC bisphenol A 269 
compared to that observed for diclofenac as a single compound. Similarly, Nair et al. (2013) observed 270 
above 90% removal of diclofenac in a mixture containing bisphenol A, 17α–ethinylestradiol and 271 
diclofenac as compared to its 70% removal in absence of the phenolic TrOCs. In another study, Hachi et 272 
al. (2017) demonstrated that an oxidative coupling agent (i.e., dimer) produced due to the degradation of 273 
acetaminophen containing an EDG (i.e., amine) formed oligomers with carbamazepine. These oligomers 274 
were more susceptible to laccase catalyzed oxidation than the parent compound, which led to enhanced 275 
carbamazepine degradation (Hachi et al., 2017). Furthermore, in nature, laccase oxidizes the aromatic 276 
rings of lignin and produce phenoxyl radical, which are responsible for the degradation of non-phenolic 277 
components of lignin (Castro et al., 2003; d’Acunzo et al., 2006). Thus, there is a strong body of evidence 278 
of TrOCs containing EDGs working as redox mediators for enhancing degradation of non-phenolics, 279 
albeit from batch tests only. The synthetic wastewater used in this study contained a mixture of TrOCs 280 
containing EDGs and EWGs, as would be expected in practical wastewater conditions. These TrOCs were 281 
well retained by the MD component during the continuous operation of the MD-EMBR (see Section 3.1). 282 
Therefore, it is possible that radicals or oxidative coupling agents formed due to the oxidation of TrOCs 283 
containing hydroxyl and amine functional groups also contributed in achieving enhanced degradation (as 284 
compared to that achieved by previously developed enzymatic bioreactors) of resistant TrOCs containing 285 
EWGs by the MD-EMBR. 286 
3.3. MD-EMBR performance with mediator addition  287 
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As noted in Section 3.2, efficient degradation (95-99%) by MD-EMBR was observed for 13 out of the 30 288 
TrOCs investigated here, while the remaining TrOCs were moderately removed (44-75%). While these 289 
removal rates compare favorably with that in previous reports, two naturally occurring redox-mediators, 290 
namely SA and VA, were added to the EMBR separately and as a mixture in an attempt to further 291 
improve removal of the recalcitrant TrOCs.  292 
Oxidation of VA and SA by laccase produces highly reactive aminoxyl and phenoxyl radicals, 293 
respectively, that have higher ORP than laccase. Moreover, these radicals act as an electron shuttle 294 
between the substrate and laccase, thereby improving the degradation of the substrate i.e., target 295 
pollutants (Ashe et al., 2016). In a study by Weng et al. (2012), addition of SA increased the ORP of the 296 
enzyme solution, consequently improving the degradation of sulphonamide antibiotics. Similarly, an 297 
increase in ORP was accompanied by an improved degradation of atrazine, pentachlorophenol, naproxen 298 
and oxybenzone following the addition of VA at a concentration of 0.5-1 mM in a batch enzymatic 299 
bioreactor (Ashe et al., 2016). In the current study, the ORP of EMBR-media increased from 0.3 to 0.39 300 
and 0.45 V following the addition of SA and VA, respectively. This was accompanied by significant 301 
improvement in TrOC removal: an increase of 5-54% depending on the molecular structure of TrOCs and 302 
redox-mediator type as discussed below (Figure 2).  303 
[Figure 2] 304 
The performance of different mediators for enhanced TrOC degradation has been reported in only a few 305 
batch or UF-EMBR studies (Ashe et al., 2016; Lloret et al., 2013; Nguyen et al., 2016). In previous 306 
studies, a continuous supply of redox-mediator was required to sustain UF-EMBR operation, because UF 307 
membranes cannot retain redox-mediators (Nguyen et al., 2014a; Nguyen et al., 2016). A uniqueness of 308 
this study is that it demonstrates the effect of the single dose of mediators on TrOC degradation following 309 
the complete retention of laccase, TrOCs and mediators by the MD membrane. SA and VA demonstrated 310 
substrate specific improvements in the degradation of TrOC that were moderately degraded by laccase-311 
only (Figure 1). Of the 17 moderately degraded TrOCs (Figure 1), the laccase-VA system achieved better 312 
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degradation for six compounds namely, ketoprofen, gemfibrozil, naproxen, primidone, carbamazepine 313 
and pentachlorophenol. By contrast, the laccase-SA system performed best for four compounds; 314 
fenoprop, clofibric acid, propoxur and atrazine (Figure 2). Similar degradation efficiency was achieved by 315 
both SA and VA for the remaining TrOCs. A comparison of TrOC fate in laccase and laccase-mediator 316 
based MD-EMBR revealed that the molecular structures of TrOCs significantly influence the 317 
effectiveness of laccase-mediator systems (Figure 3).   318 
[Figure 3] 319 
3.4. Effect of mediator mixture on TrOC degradation 320 
Since in this study, SA and VA showed different patterns of TrOC-specific degradation-improvement 321 
(Figure 2), it was envisaged that a mediator-mixture would have further beneficial effects. Degradation of 322 
the phenolic TrOCs, which were already well removed by laccase-only, remained unaffected when a SA-323 
VA mixture was used. The whole set of data is provided in Supplementary Data.  However, compared to 324 
either SA-laccase or VA-laccase, the SA-VA-laccase system did not improve the degradation of any 325 
TrOCs (Figure 4). Furthermore, in comparison to TrOC degradation by laccase-only, the SA-VA-laccase 326 
system achieved somewhat reduced degradation of six pharmaceuticals, namely ketoprofen, naproxen, 327 
clofibric acid, primidone, carbamazepine and ibuprofen (Figure 4).  328 
The performance of mediator mixtures has rarely been studied for the removal of TrOCs. Previously, Jeon 329 
et al. (2008) observed in batch tests that vanillin and acetovanillone mixture did not improve the 330 
degradation of pentachlorophenol, while enhanced pentachlorophenol degradation was found by adding a 331 
mixture of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) and vanillin or acetovanillone 332 
(Jeon et al., 2008). It is possible that, in mixtures, some mediators can chemically interact with each other 333 
instead of acting as an electron shuttle for laccase. Moreover, simultaneous addition of some mediators 334 
can reversibly inhibit laccase, thereby inhibiting electron transfer between laccase and TrOCs (Dizhbite et 335 
al., 2004; Jeon et al., 2008). Indeed, laccase inactivation was significantly increased following the 336 
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addition of SA-VA mixture (see section 3.5). The current work demonstrates for the first time through 337 
continuous operation of the MD-EMBR that although VA and SA outcompete many other mediators 338 
tested to date (Ashe et al., 2016), using them together may be counterproductive. Further studies to screen 339 
redox-mediators and their mixtures are recommended, but that is beyond the scope of the current study.  340 
 [Figure 4] 341 
3.5. Laccase stability in MD-EMBR 342 
Laccase activity in enzymatic bioreactors may be affected by various physicochemical and biological 343 
factors (Asif et al., 2017a; Purich, 2010). Transformation byproducts or charged metabolites formed 344 
following the degradation of TrOCs can block the active sites of the laccase. Moreover, hydraulic stress 345 
during MD-EMBR operation can also cause laccase inactivation (Lloret et al., 2013). Although some 346 
laccase inhibition was observed during continuous operation of the MD-EMBR (Figure 5), a stable 347 
operation could be sustained by reinjecting as little as 275-400 µL laccase solution per liter of reactor 348 
(working) volume every 12 h.  349 
[Figure 5] 350 
It may be noted that the MD membrane can theoretically retain all non-volatile compounds including 351 
redox-mediator derived highly active radicals along with laccase and TrOCs. The radicals enhance 352 
laccase-catalyzed TrOC degradation (Hachi et al., 2017), but can also instigate laccase inactivation. It has 353 
been suggested that the highly reactive radicals produced due to the oxidation of mediators can react with 354 
laccase, consequently converting them into non-productive complexes (Khlifi et al., 2010; Lloret et al., 355 
2013; Purich, 2010). Indeed, the extent of laccase inactivation increased during MD-EMBR operation 356 
after mediator addition. This data is available in Supplementary Data section. The average laccase 357 
inactivation was 53±11% (no. of laccase injections, n=4) during MD-EMBR operation in absence of 358 
mediators, while the loss in laccase activity was 57±11, 62±16 and 80±12% (n=4) after the addition of a 359 
single dose of VA, SA and SA-VA mixture, respectively (Figure 5). To date higher laccase inactivation in 360 
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presence of mediators has mostly been reported in small scale batch enzymatic bioreactors. For instance, 361 
Nguyen et al. (2014a) reported rapid laccase inactivation following the addition of SA at the tested 362 
concentrations of 0.1-1 mM in a batch enzymatic bioreactor. In another study, a complete loss of 363 
enzymatic activity was observed in a batch enzymatic bioreactor by adding VA at a concentration of 0.5 364 
mM (Ashe et al., 2016). In the current study, although laccase activity was significantly affected in the 365 
presence of redox-mediators, it was compensated for by the improvement in TrOC degradation (Figure 4).  366 
3.6. Permeate toxicity and flux  367 
Laccase-catalyzed degradation of TrOCs, particularly in the presence of mediators, produces reactive 368 
radicals and transformation products that may increase the toxicity of the treated effluent (Marco-Urrea et 369 
al., 2009; Nguyen et al., 2016). In this study, the overall bacterial toxicity of the media in the enzymatic 370 
bioreactor and MD-permeate (i.e., final effluent) was measured at the end of each EMBR run (Table 2). 371 
The media in the enzymatic bioreactor showed an overall toxicity of 5 ± 1, 14 ± 2, 65 ± 3 and 130 ± 12 372 
rTU (n=2) in presence of laccase, laccase-VA, laccase-SA and laccase-SA-VA, respectively. The 373 
observed increase in toxicity due to addition of VA and SA are consistent with previous studies (Ashe et 374 
al., 2016; Nguyen et al., 2016), however, this is the first study to report the toxicity in relation to mediator 375 
mixtures. A significantly increased toxicity following the addition of SA-VA mixture was observed. 376 
Despite the increase of toxicity in the enzymatic bioreactor, MD-EMBR permeate toxicity was below the 377 
limit of detection (i.e., rTU <1), evidencing that in addition to laccase and TrOCs, the MD system 378 
retained reactive radicals and transformation products, which cause bacterial toxicity. This is an added 379 
advantage of integrating a high retention membrane with an enzymatic bioreactor. 380 
[Table 2] 381 
[Figure 6] 382 
In this study, a stable MD-permeate flux of approximately 4 L/m2.h was achieved in all experimental 383 
conditions irrespective of redox-mediator addition, which also indicates that membrane fouling did not 384 
Page 17 of 20 
 
occur. The flux achieved here is consistent with the applied temperature differential for MD operation. 385 
Permeate flux achieved in each MD-EMBR run is given in Supplementary Data. During prolonged 386 
continuous operation, the performance of the MD process can be affected by the loss of hydrophobicity of 387 
the MD membrane (Alkhudhiri et al., 2012; Duong et al., 2017). Therefore, the integrity of the MD 388 
membrane was assessed by measuring the contact angle of the membrane after each experiment. The 389 
contact angle i.e., the hydrophobicity was found to be not significantly affected (Figure 6), confirming the 390 
suitability of combining the MD membrane with the EMBR.  391 
4. Conclusions  392 
Efficient TrOC rejection by the MD membrane appeared to be beneficial for enhanced degradation of 393 
recalcitrant TrOCs. Addition of single redox-mediators, syringaldehyde (SA) and violuric acid (VA), 394 
significantly improved the degradation of those TrOCs that were moderately degraded by laccase. Despite 395 
the compound-specific improvement observed following the separate addition of SA and VA, a mixture 396 
of SA-VA was not effective for TrOC degradation. A mediator-specific increase in the toxicity of 397 
bioreactor media was observed, but no toxicity was detected in the membrane permeate. MD-EMBR 398 
operation was stable during all experiments, and membrane wetting or fouling was not observed.     399 
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